EGFR and non-small cell lung carcinoma: Transformation from the NSCLC to SCLC usually causes strong drug resistance due to cell plasticity.248 SCLC cells often lose EGFR expression; therefore, they are resistant to EGFR inhibitors, in contrast to the nontransformed NSCLC (specifically LUAD).